The Experts below are selected from a list of 249054 Experts worldwide ranked by ideXlab platform
Chongsu Cho - One of the best experts on this subject based on the ideXlab platform.
-
mannosylated chitosan nanoparticle based cytokine gene therapy suppressed cancer growth in balb c mice bearing ct 26 carcinoma cells
Molecular Cancer Therapeutics, 2006Co-Authors: Tae Hee Kim, Hua Jin, Hyunwoo Kim, Myunghaing Cho, Chongsu ChoAbstract:Cancer immunotherapy relies on the ability of the immune system to destroy tumor cells selectively and to elicit a Long-Lasting Memory of such activity. Interleukin-12 (IL-12) is an immunomodulatory cytokine produced primarily by antigen-presenting cells, which play an important role in promoting Th1-type immune response and cell-mediated immunity. To augment the antitumor immune action by in vivo IL-12 gene delivery, mannosylated chitosan (MC) was prepared to induce mannose receptor-mediated endocytosis of IL-12 gene directly into dendritic cells which reside within the tumor. Upon characterization, MC was proven to be suitable for IL-12 gene delivery due to good physicochemical properties and low cytotoxicity. In addition, MC exhibited much enhanced IL-12 gene transfer efficiency to dendritic cells rather than chitosan itself in terms of the induction of murine IL-12 p70 and murine IFN-gamma. In animal studies, intratumoral injection of MC/plasmid encoding murine IL-12 complex into BALB/c mice bearing CT-26 carcinoma cells clearly suppressed tumor growth and angiogenesis, and significantly induced cell cycle arrest and apoptosis. Therefore, this study provides a new MC-mediated cytokine gene delivery system for cancer immunotherapy.
-
mannosylated chitosan nanoparticle based cytokine gene therapy suppressed cancer growth in balb c mice bearing ct 26 carcinoma cells
Molecular Cancer Therapeutics, 2006Co-Authors: Tae Hee Kim, Hua Jin, Hyunwoo Kim, Myunghaing Cho, Chongsu ChoAbstract:Cancer immunotherapy relies on the ability of the immune system to destroy tumor cells selectively and to elicit a Long-Lasting Memory of such activity. Interleukin-12 (IL-12) is an immunomodulatory cytokine produced primarily by antigen-presenting cells, which play an important role in promoting Th1-type immune response and cell-mediated immunity. To augment the antitumor immune action by in vivo IL-12 gene delivery, mannosylated chitosan (MC) was prepared to induce mannose receptor–mediated endocytosis of IL-12 gene directly into dendritic cells which reside within the tumor. Upon characterization, MC was proven to be suitable for IL-12 gene delivery due to good physicochemical properties and low cytotoxicity. In addition, MC exhibited much enhanced IL-12 gene transfer efficiency to dendritic cells rather than chitosan itself in terms of the induction of murine IL-12 p70 and murine IFN-γ. In animal studies, intratumoral injection of MC/plasmid encoding murine IL-12 complex into BALB/c mice bearing CT-26 carcinoma cells clearly suppressed tumor growth and angiogenesis, and significantly induced cell cycle arrest and apoptosis. Therefore, this study provides a new MC-mediated cytokine gene delivery system for cancer immunotherapy. [Mol Cancer Ther 2006;5(7):1723–32]
Tae Hee Kim - One of the best experts on this subject based on the ideXlab platform.
-
mannosylated chitosan nanoparticle based cytokine gene therapy suppressed cancer growth in balb c mice bearing ct 26 carcinoma cells
Molecular Cancer Therapeutics, 2006Co-Authors: Tae Hee Kim, Hua Jin, Hyunwoo Kim, Myunghaing Cho, Chongsu ChoAbstract:Cancer immunotherapy relies on the ability of the immune system to destroy tumor cells selectively and to elicit a Long-Lasting Memory of such activity. Interleukin-12 (IL-12) is an immunomodulatory cytokine produced primarily by antigen-presenting cells, which play an important role in promoting Th1-type immune response and cell-mediated immunity. To augment the antitumor immune action by in vivo IL-12 gene delivery, mannosylated chitosan (MC) was prepared to induce mannose receptor-mediated endocytosis of IL-12 gene directly into dendritic cells which reside within the tumor. Upon characterization, MC was proven to be suitable for IL-12 gene delivery due to good physicochemical properties and low cytotoxicity. In addition, MC exhibited much enhanced IL-12 gene transfer efficiency to dendritic cells rather than chitosan itself in terms of the induction of murine IL-12 p70 and murine IFN-gamma. In animal studies, intratumoral injection of MC/plasmid encoding murine IL-12 complex into BALB/c mice bearing CT-26 carcinoma cells clearly suppressed tumor growth and angiogenesis, and significantly induced cell cycle arrest and apoptosis. Therefore, this study provides a new MC-mediated cytokine gene delivery system for cancer immunotherapy.
-
mannosylated chitosan nanoparticle based cytokine gene therapy suppressed cancer growth in balb c mice bearing ct 26 carcinoma cells
Molecular Cancer Therapeutics, 2006Co-Authors: Tae Hee Kim, Hua Jin, Hyunwoo Kim, Myunghaing Cho, Chongsu ChoAbstract:Cancer immunotherapy relies on the ability of the immune system to destroy tumor cells selectively and to elicit a Long-Lasting Memory of such activity. Interleukin-12 (IL-12) is an immunomodulatory cytokine produced primarily by antigen-presenting cells, which play an important role in promoting Th1-type immune response and cell-mediated immunity. To augment the antitumor immune action by in vivo IL-12 gene delivery, mannosylated chitosan (MC) was prepared to induce mannose receptor–mediated endocytosis of IL-12 gene directly into dendritic cells which reside within the tumor. Upon characterization, MC was proven to be suitable for IL-12 gene delivery due to good physicochemical properties and low cytotoxicity. In addition, MC exhibited much enhanced IL-12 gene transfer efficiency to dendritic cells rather than chitosan itself in terms of the induction of murine IL-12 p70 and murine IFN-γ. In animal studies, intratumoral injection of MC/plasmid encoding murine IL-12 complex into BALB/c mice bearing CT-26 carcinoma cells clearly suppressed tumor growth and angiogenesis, and significantly induced cell cycle arrest and apoptosis. Therefore, this study provides a new MC-mediated cytokine gene delivery system for cancer immunotherapy. [Mol Cancer Ther 2006;5(7):1723–32]
Myunghaing Cho - One of the best experts on this subject based on the ideXlab platform.
-
mannosylated chitosan nanoparticle based cytokine gene therapy suppressed cancer growth in balb c mice bearing ct 26 carcinoma cells
Molecular Cancer Therapeutics, 2006Co-Authors: Tae Hee Kim, Hua Jin, Hyunwoo Kim, Myunghaing Cho, Chongsu ChoAbstract:Cancer immunotherapy relies on the ability of the immune system to destroy tumor cells selectively and to elicit a Long-Lasting Memory of such activity. Interleukin-12 (IL-12) is an immunomodulatory cytokine produced primarily by antigen-presenting cells, which play an important role in promoting Th1-type immune response and cell-mediated immunity. To augment the antitumor immune action by in vivo IL-12 gene delivery, mannosylated chitosan (MC) was prepared to induce mannose receptor-mediated endocytosis of IL-12 gene directly into dendritic cells which reside within the tumor. Upon characterization, MC was proven to be suitable for IL-12 gene delivery due to good physicochemical properties and low cytotoxicity. In addition, MC exhibited much enhanced IL-12 gene transfer efficiency to dendritic cells rather than chitosan itself in terms of the induction of murine IL-12 p70 and murine IFN-gamma. In animal studies, intratumoral injection of MC/plasmid encoding murine IL-12 complex into BALB/c mice bearing CT-26 carcinoma cells clearly suppressed tumor growth and angiogenesis, and significantly induced cell cycle arrest and apoptosis. Therefore, this study provides a new MC-mediated cytokine gene delivery system for cancer immunotherapy.
-
mannosylated chitosan nanoparticle based cytokine gene therapy suppressed cancer growth in balb c mice bearing ct 26 carcinoma cells
Molecular Cancer Therapeutics, 2006Co-Authors: Tae Hee Kim, Hua Jin, Hyunwoo Kim, Myunghaing Cho, Chongsu ChoAbstract:Cancer immunotherapy relies on the ability of the immune system to destroy tumor cells selectively and to elicit a Long-Lasting Memory of such activity. Interleukin-12 (IL-12) is an immunomodulatory cytokine produced primarily by antigen-presenting cells, which play an important role in promoting Th1-type immune response and cell-mediated immunity. To augment the antitumor immune action by in vivo IL-12 gene delivery, mannosylated chitosan (MC) was prepared to induce mannose receptor–mediated endocytosis of IL-12 gene directly into dendritic cells which reside within the tumor. Upon characterization, MC was proven to be suitable for IL-12 gene delivery due to good physicochemical properties and low cytotoxicity. In addition, MC exhibited much enhanced IL-12 gene transfer efficiency to dendritic cells rather than chitosan itself in terms of the induction of murine IL-12 p70 and murine IFN-γ. In animal studies, intratumoral injection of MC/plasmid encoding murine IL-12 complex into BALB/c mice bearing CT-26 carcinoma cells clearly suppressed tumor growth and angiogenesis, and significantly induced cell cycle arrest and apoptosis. Therefore, this study provides a new MC-mediated cytokine gene delivery system for cancer immunotherapy. [Mol Cancer Ther 2006;5(7):1723–32]
Hyunwoo Kim - One of the best experts on this subject based on the ideXlab platform.
-
mannosylated chitosan nanoparticle based cytokine gene therapy suppressed cancer growth in balb c mice bearing ct 26 carcinoma cells
Molecular Cancer Therapeutics, 2006Co-Authors: Tae Hee Kim, Hua Jin, Hyunwoo Kim, Myunghaing Cho, Chongsu ChoAbstract:Cancer immunotherapy relies on the ability of the immune system to destroy tumor cells selectively and to elicit a Long-Lasting Memory of such activity. Interleukin-12 (IL-12) is an immunomodulatory cytokine produced primarily by antigen-presenting cells, which play an important role in promoting Th1-type immune response and cell-mediated immunity. To augment the antitumor immune action by in vivo IL-12 gene delivery, mannosylated chitosan (MC) was prepared to induce mannose receptor-mediated endocytosis of IL-12 gene directly into dendritic cells which reside within the tumor. Upon characterization, MC was proven to be suitable for IL-12 gene delivery due to good physicochemical properties and low cytotoxicity. In addition, MC exhibited much enhanced IL-12 gene transfer efficiency to dendritic cells rather than chitosan itself in terms of the induction of murine IL-12 p70 and murine IFN-gamma. In animal studies, intratumoral injection of MC/plasmid encoding murine IL-12 complex into BALB/c mice bearing CT-26 carcinoma cells clearly suppressed tumor growth and angiogenesis, and significantly induced cell cycle arrest and apoptosis. Therefore, this study provides a new MC-mediated cytokine gene delivery system for cancer immunotherapy.
-
mannosylated chitosan nanoparticle based cytokine gene therapy suppressed cancer growth in balb c mice bearing ct 26 carcinoma cells
Molecular Cancer Therapeutics, 2006Co-Authors: Tae Hee Kim, Hua Jin, Hyunwoo Kim, Myunghaing Cho, Chongsu ChoAbstract:Cancer immunotherapy relies on the ability of the immune system to destroy tumor cells selectively and to elicit a Long-Lasting Memory of such activity. Interleukin-12 (IL-12) is an immunomodulatory cytokine produced primarily by antigen-presenting cells, which play an important role in promoting Th1-type immune response and cell-mediated immunity. To augment the antitumor immune action by in vivo IL-12 gene delivery, mannosylated chitosan (MC) was prepared to induce mannose receptor–mediated endocytosis of IL-12 gene directly into dendritic cells which reside within the tumor. Upon characterization, MC was proven to be suitable for IL-12 gene delivery due to good physicochemical properties and low cytotoxicity. In addition, MC exhibited much enhanced IL-12 gene transfer efficiency to dendritic cells rather than chitosan itself in terms of the induction of murine IL-12 p70 and murine IFN-γ. In animal studies, intratumoral injection of MC/plasmid encoding murine IL-12 complex into BALB/c mice bearing CT-26 carcinoma cells clearly suppressed tumor growth and angiogenesis, and significantly induced cell cycle arrest and apoptosis. Therefore, this study provides a new MC-mediated cytokine gene delivery system for cancer immunotherapy. [Mol Cancer Ther 2006;5(7):1723–32]
Hua Jin - One of the best experts on this subject based on the ideXlab platform.
-
mannosylated chitosan nanoparticle based cytokine gene therapy suppressed cancer growth in balb c mice bearing ct 26 carcinoma cells
Molecular Cancer Therapeutics, 2006Co-Authors: Tae Hee Kim, Hua Jin, Hyunwoo Kim, Myunghaing Cho, Chongsu ChoAbstract:Cancer immunotherapy relies on the ability of the immune system to destroy tumor cells selectively and to elicit a Long-Lasting Memory of such activity. Interleukin-12 (IL-12) is an immunomodulatory cytokine produced primarily by antigen-presenting cells, which play an important role in promoting Th1-type immune response and cell-mediated immunity. To augment the antitumor immune action by in vivo IL-12 gene delivery, mannosylated chitosan (MC) was prepared to induce mannose receptor-mediated endocytosis of IL-12 gene directly into dendritic cells which reside within the tumor. Upon characterization, MC was proven to be suitable for IL-12 gene delivery due to good physicochemical properties and low cytotoxicity. In addition, MC exhibited much enhanced IL-12 gene transfer efficiency to dendritic cells rather than chitosan itself in terms of the induction of murine IL-12 p70 and murine IFN-gamma. In animal studies, intratumoral injection of MC/plasmid encoding murine IL-12 complex into BALB/c mice bearing CT-26 carcinoma cells clearly suppressed tumor growth and angiogenesis, and significantly induced cell cycle arrest and apoptosis. Therefore, this study provides a new MC-mediated cytokine gene delivery system for cancer immunotherapy.
-
mannosylated chitosan nanoparticle based cytokine gene therapy suppressed cancer growth in balb c mice bearing ct 26 carcinoma cells
Molecular Cancer Therapeutics, 2006Co-Authors: Tae Hee Kim, Hua Jin, Hyunwoo Kim, Myunghaing Cho, Chongsu ChoAbstract:Cancer immunotherapy relies on the ability of the immune system to destroy tumor cells selectively and to elicit a Long-Lasting Memory of such activity. Interleukin-12 (IL-12) is an immunomodulatory cytokine produced primarily by antigen-presenting cells, which play an important role in promoting Th1-type immune response and cell-mediated immunity. To augment the antitumor immune action by in vivo IL-12 gene delivery, mannosylated chitosan (MC) was prepared to induce mannose receptor–mediated endocytosis of IL-12 gene directly into dendritic cells which reside within the tumor. Upon characterization, MC was proven to be suitable for IL-12 gene delivery due to good physicochemical properties and low cytotoxicity. In addition, MC exhibited much enhanced IL-12 gene transfer efficiency to dendritic cells rather than chitosan itself in terms of the induction of murine IL-12 p70 and murine IFN-γ. In animal studies, intratumoral injection of MC/plasmid encoding murine IL-12 complex into BALB/c mice bearing CT-26 carcinoma cells clearly suppressed tumor growth and angiogenesis, and significantly induced cell cycle arrest and apoptosis. Therefore, this study provides a new MC-mediated cytokine gene delivery system for cancer immunotherapy. [Mol Cancer Ther 2006;5(7):1723–32]
